158 related articles for article (PubMed ID: 8311852)
21. Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis.
Ostendorf T; Rong S; Boor P; Wiedemann S; Kunter U; Haubold U; van Roeyen CR; Eitner F; Kawachi H; Starling G; Alvarez E; Smithson G; Floege J
J Am Soc Nephrol; 2006 Apr; 17(4):1054-62. PubMed ID: 16510766
[TBL] [Abstract][Full Text] [Related]
22. Platelet-derived growth factor and fibroblast growth factor differentially regulate interleukin 1beta- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells.
Kunz D; Walker G; Eberhardt W; Messmer UK; Huwiler A; Pfeilschifter J
J Clin Invest; 1997 Dec; 100(11):2800-9. PubMed ID: 9389745
[TBL] [Abstract][Full Text] [Related]
23. Expression of the transcriptional regulator Egr-1 in experimental glomerulonephritis: requirement for mesangial cell proliferation.
Rupprecht HD; Hoffer G; de Heer E; Sterzel RB; Faller G; Schoecklmann HO
Kidney Int; 1997 Mar; 51(3):694-702. PubMed ID: 9067901
[TBL] [Abstract][Full Text] [Related]
24. Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF in vivo.
Hugo C; Pichler R; Meek R; Gordon K; Kyriakides T; Floege J; Bornstein P; Couser WG; Johnson RJ
Kidney Int; 1995 Dec; 48(6):1846-56. PubMed ID: 8587244
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of mesangial cell proliferation by platelet factor 4.
Barnes JL; Woodruff KA; Levine SP; Abboud HE
J Am Soc Nephrol; 1996 Jul; 7(7):991-8. PubMed ID: 8829113
[TBL] [Abstract][Full Text] [Related]
26. Beneficial effects of a novel inhibitor of platelet-derived growth factor receptor autophosphorylation in the rat with mesangial proliferative glomerulonephritis.
Yagi M; Kato S; Kobayashi Y; Kobayashi N; Iinuma N; Nakamura K; Kubo K; Ohyama SI; Murooka H; Shimizu T; Nishitoba T; Osawa T; Nagano N
Gen Pharmacol; 1998 Nov; 31(5):765-73. PubMed ID: 9809476
[TBL] [Abstract][Full Text] [Related]
27. Requirement of cyclin D1 in mesangial cell mitogenesis.
Lang S; Hartner A; Sterzel RB; Schöcklmann HO
J Am Soc Nephrol; 2000 Aug; 11(8):1398-1408. PubMed ID: 10906153
[TBL] [Abstract][Full Text] [Related]
28. Cold Shock Proteins Mediate GN with Mesangioproliferation.
Zhu C; Sauter E; Schreiter A; van Roeyen CR; Ostendorf T; Floege J; Gembardt F; Hugo CP; Isermann B; Lindquist JA; Mertens PR
J Am Soc Nephrol; 2016 Dec; 27(12):3678-3689. PubMed ID: 27151923
[TBL] [Abstract][Full Text] [Related]
29. The role of PDGF-D in mesangioproliferative glomerulonephritis.
Floege J; van Roeyen C; Boor P; Ostendorf T
Contrib Nephrol; 2007; 157():153-8. PubMed ID: 17495455
[TBL] [Abstract][Full Text] [Related]
30. Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats.
Floege J; Eng E; Young BA; Alpers CE; Barrett TB; Bowen-Pope DF; Johnson RJ
J Clin Invest; 1993 Dec; 92(6):2952-62. PubMed ID: 7902849
[TBL] [Abstract][Full Text] [Related]
31. LPA as a determinant of mesangial growth and apoptosis.
Inoue CN
Semin Nephrol; 2002 Sep; 22(5):415-22. PubMed ID: 12224049
[TBL] [Abstract][Full Text] [Related]
32. Role of platelet-derived growth factor in renal injury.
Abboud HE
Annu Rev Physiol; 1995; 57():297-309. PubMed ID: 7778870
[TBL] [Abstract][Full Text] [Related]
33. Alpha1beta1 integrin-mediated collagen matrix remodeling by rat mesangial cells is differentially regulated by transforming growth factor-beta and platelet-derived growth factor-BB.
Kagami S; Kondo S; Löster K; Reutter W; Kuhara T; Yasutomo K; Kuroda Y
J Am Soc Nephrol; 1999 Apr; 10(4):779-89. PubMed ID: 10203362
[TBL] [Abstract][Full Text] [Related]
34. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo.
Hugo CP; Pichler RP; Schulze-Lohoff E; Pröls F; Adler S; Krutsch HC; Murphy-Ullrich JE; Couser WG; Roberts DD; Johnson RJ
Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272
[TBL] [Abstract][Full Text] [Related]
35. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
[TBL] [Abstract][Full Text] [Related]
36. Exogenous PDGF-D is a potent mesangial cell mitogen and causes a severe mesangial proliferative glomerulopathy.
Hudkins KL; Gilbertson DG; Carling M; Taneda S; Hughes SD; Holdren MS; Palmer TE; Topouzis S; Haran AC; Feldhaus AL; Alpers CE
J Am Soc Nephrol; 2004 Feb; 15(2):286-98. PubMed ID: 14747375
[TBL] [Abstract][Full Text] [Related]
37. Lysophosphatidic acid and platelet-derived growth factor synergistically stimulate growth of cultured rat mesangial cells.
Inoue CN; Ko YH; Guggino WB; Forster HG; Epstein M
Proc Soc Exp Biol Med; 1997 Dec; 216(3):370-9. PubMed ID: 9402141
[TBL] [Abstract][Full Text] [Related]
38. High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells.
Di Paolo S; Gesualdo L; Ranieri E; Grandaliano G; Schena FP
Am J Pathol; 1996 Dec; 149(6):2095-106. PubMed ID: 8952542
[TBL] [Abstract][Full Text] [Related]
39. Altered cultured mesangial cell phenotypes from RF/J mice: a spontaneous immune complex mediated glomerulonephritis with progressive glomerulosclerosis.
Yashiro M; Muso E; Kamata T; Oyama A; Sasayama S; Yoshida H
Exp Nephrol; 2001; 9(6):420-7. PubMed ID: 11702002
[TBL] [Abstract][Full Text] [Related]
40. Selective inhibition of platelet-derived growth factor (PDGF) receptor autophosphorylation and PDGF-mediated cellular events by a quinoline derivative.
Yagi M; Kato S; Kobayashi Y; Kubo K; Oyama S; Shimizu T; Nishitoba T; Isoe T; Nakamura K; Ohashi H; Kobayashi N; Iinuma N; Osawa T; Onose R; Osada H
Exp Cell Res; 1997 Aug; 234(2):285-92. PubMed ID: 9260896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
